- Home
- EVGO vs AMLX Comparison
EVGO vs AMLX Comparison
Compare EVGO & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGO
- AMLX
- Stock Information
- Founded
- EVGO 2010
- AMLX 2014
- Country
- EVGO United States
- AMLX United States
- Employees
- EVGO N/A
- AMLX N/A
- Industry
- EVGO Other Specialty Stores
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- EVGO Consumer Discretionary
- AMLX Health Care
- Exchange
- EVGO Nasdaq
- AMLX Nasdaq
- Market Cap
- EVGO 674.8M
- AMLX 749.9M
- IPO Year
- EVGO N/A
- AMLX 2022
- Fundamental
- Price
- EVGO $3.67
- AMLX $13.75
- Analyst Decision
- EVGO Buy
- AMLX Strong Buy
- Analyst Count
- EVGO 8
- AMLX 7
- Target Price
- EVGO $5.70
- AMLX $16.86
- AVG Volume (30 Days)
- EVGO 3.7M
- AMLX 1.6M
- Earning Date
- EVGO 11-10-2025
- AMLX 11-06-2025
- Dividend Yield
- EVGO N/A
- AMLX N/A
- EPS Growth
- EVGO N/A
- AMLX N/A
- EPS
- EVGO N/A
- AMLX N/A
- Revenue
- EVGO $308,365,000.00
- AMLX N/A
- Revenue This Year
- EVGO $45.13
- AMLX N/A
- Revenue Next Year
- EVGO $26.83
- AMLX N/A
- P/E Ratio
- EVGO N/A
- AMLX N/A
- Revenue Growth
- EVGO 49.06
- AMLX N/A
- 52 Week Low
- EVGO $2.20
- AMLX $2.60
- 52 Week High
- EVGO $8.09
- AMLX $16.96
- Technical
- Relative Strength Index (RSI)
- EVGO 34.80
- AMLX 49.35
- Support Level
- EVGO $3.81
- AMLX $13.54
- Resistance Level
- EVGO $4.11
- AMLX $14.63
- Average True Range (ATR)
- EVGO 0.21
- AMLX 0.82
- MACD
- EVGO -0.07
- AMLX -0.26
- Stochastic Oscillator
- EVGO 0.93
- AMLX 16.49
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.